DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+3.04%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$118M
AUM Growth
+$118M
(-9.2%)
Cap. Flow
-$17.6M
Cap. Flow
% of AUM
-14.86%
Top 10 Holdings %
Top 10 Hldgs %
43.16%
Holding
93
New
21
Increased
10
Reduced
13
Closed
18
Top Buys
| 1 |
AbbVie
ABBV
|
$7.83M |
| 2 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$2.64M |
| 3 |
XNPT
XENOPORT, INC.
XNPT
|
$2.54M |
| 4 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$2.11M |
| 5 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$1.73M |
Top Sells
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$18.3M |
| 2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$12.1M |
| 3 |
MTEM
Molecular Templates, Inc.
MTEM
|
$2.54M |
| 4 |
AtriCure
ATRC
|
$2.19M |
| 5 |
Masimo
MASI
|
$774K |
Sector Composition
| 1 | Healthcare | 73.78% |
| 2 | Financials | 0.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
76
DELISTED
Epizyme, Inc
EPZM
| – | – |
-20,000
| Closed | -$376K |
|
|
APEN
77
DELISTED
Apollo Endosurgery, Inc.
APEN
| – | – |
-111,884
| Closed | -$276K |
|
|
MTEM
78
DELISTED
Molecular Templates, Inc.
MTEM
| – | – |
-625,558
| Closed | -$2.54M |
|
|
CUTR
79
DELISTED
Cutera, Inc.
CUTR
| – | – |
-23,490
| Closed | -$303K |
|
80
Tonix Pharmaceuticals
TNXP
$243M
| – | – |
0
-14,400
| -100% | -$91K |
|
81
Minerva Neurosciences
NERV
$16.8M
| – | – |
-101,317
| Closed | -$507K |
|
82
Fate Therapeutics
FATE
$115M
| – | – |
-20,190
| Closed | -$99K |
|
83
Curis
CRIS
$21.5M
| – | – |
-299,800
| Closed | -$720K |
|
84
Apyx Medical
APYX
$71.9M
| – | – |
-100,000
| Closed | -$239K |
|
85
Aldeyra Therapeutics
ALDX
$350M
| – | – |
-35,000
| Closed | -$356K |
|
|
ACER
86
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| – | – |
-500
| Closed | – |
|